Full Thickness Mucoperiosteal Flap Versus Low Level Laser in Orthodontic Tooth Movement Acceleration
Evaluation of the Effect of Full Thickness Mucoperiosteal Flap Versus Low Level Laser in Orthodontic Tooth Movement Acceleration
1 other identifier
interventional
32
1 country
1
Brief Summary
This study aimed to evaluate the effect of using full thickness mucoperiosteal flap (FTMPF) elevation only versus low level laser therapy (LLLT) on acceleration of orthodontic tooth movement.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Sep 2017
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2019
CompletedFirst Submitted
Initial submission to the registry
July 30, 2019
CompletedFirst Posted
Study publicly available on registry
August 14, 2019
CompletedAugust 20, 2019
August 1, 2019
1.6 years
July 30, 2019
August 18, 2019
Conditions
Outcome Measures
Primary Outcomes (1)
rate of orthodontic tooth movement acceleration determination by measuring the rate of maxillary canine retraction
measure the rate of canine retraction on series of study models
the rate of retraction( distance from the first day of retraction to the end of retraction/ time)) it was with total time frame 24 weeks for starting of retraction
Secondary Outcomes (1)
clinical mesial movement of first maxillary molar measured by millimeter on the 3D model
t0(start of canine retraction) to 24 months
Study Arms (4)
full thickness mucoperiosteal flap
EXPERIMENTALA full thickness mucoperiosteal flap (FTMPF) was reflected on FTMPF side at the maxillary canine/premolar region by the same surgeon for all patients following the same procedures.
low level laser therapy
EXPERIMENTALLLLT was done using a diode soft laser (Epic X, BioLase, USA). It is a semiconductor diode soft laser. Active medium is In-Ga-As with 940nm wave length
Control for Full thickness mucoperiosteal flap
NO INTERVENTIONControl for Full thickness mucoperiosteal flap, in which canine retraction was done in a conventional method
control for Low level laser therapy group
NO INTERVENTIONControl for Low level laser therapy , in which canine retraction was done in a conventional method
Interventions
A free gingival sulcular incision was done from the distal surface of maxillary second premolar to the mesial side of the maxillary canine. A releasing oblique incision was done including the interdental papilla between maxillary canine and lateral incisor extending to the mucogingival junction just beyond the attached mucosa. The flap reflection extended beyond the canine root apex. A FTMPF reflection was done with mucoperiosteal elevator. Free sulcus incision was done to allow elevation of palatal mucosa by tunneling technique on the palatal gingiva of maxillary canine.
LLLT was done using a diode soft laser (Epic X, BioLase, USA). It is a semiconductor diode soft laser. Active medium is In-Ga-As with 940nm wave length. LLLT protocol was using active laser tip (bleaching tip)
Eligibility Criteria
You may qualify if:
- o Free of any syndromes affecting the head region or any craniofacial injuries.
- No history of previous orthodontic treatment
- All of the permanent dentition present excluding third molars.
- Good oral hygiene before starting treatment.
- Cases indicated for extraction of the maxillary first premolars and canine retraction into the extraction space with maximum anchorage.
- Malocclusion cases that allow initial stage of leveling and alignment without extraction.
You may not qualify if:
- o Patients with systemic diseases especially bleeding disorders and osteoporosis.
- History of administration of corticosteroids, exogenous hormones and non-steroidal anti-inflammatory drugs (all drugs interfere with OTM).
- Presence of previous history of oral surgeries in maxillary arch.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Faculty of dentistry ,Al-Azhar Univerisity
Cairo, Naser City, 7118, Egypt
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Mohsena a arazik, orthodontist
Al-Azhar University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- FACTORIAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant lecturer of orthodontics
Study Record Dates
First Submitted
July 30, 2019
First Posted
August 14, 2019
Study Start
September 1, 2017
Primary Completion
April 1, 2019
Study Completion
June 1, 2019
Last Updated
August 20, 2019
Record last verified: 2019-08
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF
- Time Frame
- by today,()30July 2019
- Access Criteria
- Google drive
the data will be shared the weekly rate and distance of canine retraction, the amount of maxillary canine mesial movement and the periodontal pocket depth around the maxillary canine